MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Longitudinal Relationship Between Brain Metabolism and Clinical Changes in Huntington’s Disease

A. Gravier, S. Lavisse, R. Massart, A. Gil-Salcedo, P. Lemercier, O. Barret, V. Gaura, AC. Bachoud-Levi, P. Remy (Créteil, France)

Meeting: 2024 International Congress

Abstract Number: 1462

Keywords: Cognitive dysfunction, Positron emission tomography(PET), Resting brain metabolism

Category: Huntington's Disease

Objective: To understand the relationship between progression of the clinical symptoms and patterns of brain hypometabolism progression in a large cohort of Huntington’s disease (HD) patients.

Background: Striatal atrophy is present in the preclinical phase of HD and extends to the posterior cortical regions. Atrophy has been correlated with clinical markers. However, atrophy is a late marker of disease severity, related to neuronal death. FDG-PET imaging studies have reported discordant topographical changes of brain hypometabolism compared to cortical atrophy in HD patients. Regional brain metabolism has been transversally correlated with clinical symptoms but no longitudinal study has used FDG-PET to analyze the relationships between evolution of brain metabolism and clinical markers.

Method: Data were extracted from MIG-HD trial (NCT00190450). Thirty-four HD patients were included with a total motor score (TMS) >5 and a total functional capacity (TFC) score >9.

Motor, functional and cognitive evaluations were performed at inclusion and over follow up for 4 years. PET imaging was performed at 12 (PET1), 32 (PET2) and 52 months (PET3) after inclusion.

Regions of interest were clustered according to their metabolism transversally at PET1 and longitudinally over the whole follow-up using a weighted gene correlation network analysis (WGCNA). Metabolism in each cluster was correlated to the clinical variables at PET1 using WGCNA and evolution of brain metabolism in each cluster was also correlated to the evolution of the clinical parameters.

Results: There was a significant overall reduction of metabolism which was more pronounced in subcortical and anterior cortical regions with relatively spared posterior cortical areas over the whole follow-up.

Significant correlations at PET1 were mainly observed between metabolism in basal ganglia and TFC, UHDRS-dependance, motor scores, cUHDRS, Mattis dementia rating scale (MDRS) and categorial verbal fluency. Conversely, main correlations over follow-up were observed between the evolution of metabolism in cortical areas and several cognitive scores such as categorial fluency, figure cancellation task, MDRS and SDMT.

Conclusion: Our data suggest that striatal hypometabolism plays a major role in the cognitive deficits at the early stage of HD, whereas further progression of cognitive decline is more related to the spreading of hypometabolism from anterior to posterior cortical areas.

To cite this abstract in AMA style:

A. Gravier, S. Lavisse, R. Massart, A. Gil-Salcedo, P. Lemercier, O. Barret, V. Gaura, AC. Bachoud-Levi, P. Remy. Longitudinal Relationship Between Brain Metabolism and Clinical Changes in Huntington’s Disease [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/longitudinal-relationship-between-brain-metabolism-and-clinical-changes-in-huntingtons-disease/. Accessed July 1, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/longitudinal-relationship-between-brain-metabolism-and-clinical-changes-in-huntingtons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley